Sirolimus can promote the disappearance of renal angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sirolimus can promote the disappearance of renal angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
Authors
Keywords
-
Journal
World Journal of Pediatrics
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-29
DOI
10.1007/s12519-023-00751-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sirolimus can Increase the Disappearance Rate of Cardiac Rhabdomyomas Associated with Tuberous Sclerosis: A Prospective Cohort and Self-controlled Case Series Study
- (2021) Xiao-Qiao Chen et al. JOURNAL OF PEDIATRICS
- Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
- (2021) Cong Luo et al. Orphanet Journal of Rare Diseases
- Fate of Pediatric Renal Angiomyolipoma During mTOR Inhibitor Treatment in Tuberous Sclerosis Complex
- (2020) Charlotte Q. Wu et al. UROLOGY
- Sirolimus improves seizure control in pediatric patients with tuberous sclerosis: A prospective cohort study
- (2020) Wen He et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Natural History of Renal Angiomyolipoma Favors Surveillance as an Initial Approach
- (2020) Gregory J. Nason et al. European Urology Focus
- CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex
- (2019) Wenda Wang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness
- (2018) J Chris Kingswood et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis
- (2018) John J. Bissler et al. PLoS One
- Pediatric Renal Angiomyolipomas in Tuberous Sclerosis Complex
- (2017) Jason C. Warncke et al. JOURNAL OF UROLOGY
- The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma
- (2017) John J. Bissler et al. PEDIATRIC NEPHROLOGY
- Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas
- (2017) Elyse Swallow et al. UROLOGY
- Causes of mortality in individuals with tuberous sclerosis complex
- (2016) Sam Amin et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy
- (2016) Jaimin R. Bhatt et al. EUROPEAN UROLOGY
- Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?
- (2016) Samy L Habib et al. Journal of Cancer
- Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
- (2015) Jeffrey P. MacKeigan et al. NEURO-ONCOLOGY
- Novel targets of antifibrotic and anti-inflammatory treatment in CKD
- (2014) Anne-Emilie Declèves et al. Nature Reviews Nephrology
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Darcy A. Krueger et al. PEDIATRIC NEUROLOGY
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
- (2012) Cristina Cabrera-López et al. Orphanet Journal of Rare Diseases
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
- (2011) Markus Gödel et al. JOURNAL OF CLINICAL INVESTIGATION
- Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
- (2011) Sandra L. Dabora et al. PLoS One
- Validation of the revised Schwartz estimating equation in a predominantly non-CKD population
- (2010) Amy Staples et al. PEDIATRIC NEPHROLOGY
- The radiological diagnosis and treatment of renal angiomyolipoma—current status
- (2009) D. Halpenny et al. CLINICAL RADIOLOGY
- New Equations to Estimate GFR in Children with CKD
- (2009) G. J. Schwartz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Tuberous sclerosis
- (2008) Paolo Curatolo et al. LANCET
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now